Literature Review
Literature Review
Stem cell transplants are more effective than some MS therapies
The results of the new study are “encouraging,” but plenty of unanswered questions remain.
Literature Review
Biosimilar equal to natalizumab for relapsing remitting MS
Biosim-NTZ is the first biosimilar monoclonal antibody therapy to be developed for MS.
Literature Review
Stem cell transplant superior to DMTs for secondary progressive MS
More than 60% of patients with SPMS who received AHSCT were free from disability progression at 5 years.
Literature Review
Four-gene signature linked to increased PML risk
Investigators have identified four immune-associated genes that put immunocompromised patients at risk for progressive multifocal...
Literature Review
High drug costs exclude most neurology patients from cutting-edge treatment
“Our study of people with neurologic conditions found that fewer than 20% were being treated with new medications.”
Literature Review
New framework for MS diagnosis and treatment proposed
The new framework is based on underlying biology of disease and acknowledges the different trajectories of individual patients.
News
One in three MS patients reports chronic itch
Itch is historically underrecognized as a symptom of MS, but physicians should know that it is common and may negatively impact quality of life....
Literature Review
Ublituximab bests teriflunomide in head-to-head clinical trials
The results of the ULTIMATE I and II trials may pave the way for ublituximab’s approval as the third high-efficacy anti-CD20 monoclonal antibody...
News
Childhood abuse may increase risk of MS in women
Women exposed to all three types of abuse – emotional, physical, and sexual – had the highest risk of MS, at 93%.
News
MS plus depression can increase risk of death, vascular disease
“The effects of depression and MS on all-cause mortality are synergistic.”